Skip to content
WeighLab
Menu
Ranked #274 · Grade C

Layla review

Layla is a US telehealth weight-loss brand that now sells only FDA-approved branded GLP-1s Ozempic, Wegovy, Zepbound and Mounjaro starting around $1,399/mo, all-inclusive of health check-ins, telehealth visits and unlimited doctor messaging.

Visit Layla Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes the Cost-Efficiency Index. See our disclosure.
Semaglutide
$1,399/mo (brand Ozempic, promotional rate)
Tirzepatide
$1,399/mo (brand Mounjaro, promotional rate)
Coverage
Coverage not published
Brand-name
Yes

Semaglutide · modeled / year

$16,788

Tirzepatide · modeled / year

$16,788

Pricing verified August 2026

The Index scorecard

Layla scored on our six Cost-Efficiency Index factors. See the methodology.

Normalized Cost/Month41/100
Price Transparency78/100
Nationwide Access24/100
Formulation Options90/100
Clinical Oversight81/100
Contract Flexibility55/100

Where the value is

  • All-inclusive pricing bundles health check-ins, telehealth visits, prescription and unlimited doctor messaging into one price
  • Named Medical Director (Dr. Ruth Cohen) disclosed on-site
  • LegitScript-certified badge displayed; fast 2-3 day shipping claimed

The tradeoffs

  • Brand-only and expensive: the real floor is $1,399/mo (Ozempic/Mounjaro), not the $1,299 the homepage FAQ separately claims — the two figures don't reconcile
  • The lowest Zepbound figure shown ($1,599) is a one-time new-customer discount off a $1,699 standing price, not an ongoing rate
  • No compounded or lower-cost option currently found on the site, despite older data suggesting one existed; states served are not published
  • $100 nonrefundable visit/clinical fee applies if you cancel after a prescription is already sent to the pharmacy

The bottom line

Best for: Cost-first shoppers who want brand-name GLP-1 access from shoppers who don't need a compounded/lower-cost option. Layla is a US telehealth weight-loss brand that now sells only FDA-approved branded GLP-1s Ozempic, Wegovy, Zepbound and Mounjaro starting around $1,399/mo, all-inclusive of health check-ins, telehealth visits and unlimited doctor messaging.

Ranked #274 of 539 providers on the Cost-Efficiency Index — see our #1 pick, CoreAge Rx, for comparison.

Compare with other providers

All 538 other providers we've modeled, in Cost-Efficiency Index order. See the ranked alternatives to Layla.

The 24 programs nearest this one

Pricing, states and verification reflect Layla's public disclosures at last review; the Cost-Efficiency Index is our editorial judgment per the methodology. Prices change — confirm on Layla's site. Not medical advice; see our disclosure.

← Back to the value leaderboard